1 employees
Therasid Bioscience develops therapies for treating non-alcoholic steatohepatitis and Alzheimer’s disease.
2017
Therasid Bioscience raised undisclosed on July 5, 2019
Investors: AJU IB INVESTMENT, Hb Investment and GNTech Venture Capital | 지앤텍벤처투자